Epstein Secrets

vaccine before." USA Today <https://www.usatoday.corn/stoty/news/2020/07/27/large-scale-trials- possible-covid-19-vaccines-begin/5518981002/> (7/27, Weintraub, 10.31M), the Washington Times <https://www.washingtontimes.corn/news/2020/jul/27/virus-vaccine-put-to-final-test-in-thousands-of-vo/> (7/27, Neerg

cine-trial-update- novembed> (7/27, Siddons, 154K) and New York Times <https://vvww.nytimes.cotn/2020/07/27/health/modema-vaccine-covid.html> (7/27, Grady, 18.61M), among other news outlets, also report the story. CNBC <https://www.cnbc.cotn/2020/07/27/moderna-shares-soar-after-us-ups-funding-for-coro

" USA Today <https://www.usatoday.corn/story/news/health/2020/11/30/modema-emergency-fda-authorization- covid-19-vaccine-pfizer/6376336002/> (11/30, Weintraub, 10.31M) reports Modema's latest findings "showed that of 196 people in the clinical trial who caught COVID-19, 185 of them had received the placebo

ith a greater proportion of residents at high risk." The New York Times <https://www.nytimes.com/live/2020/11/30/world/covid-19-coronavirus> (11/30, Grady, Zraick, 18.61M) reports that on Monday, when "asked about the role of states in the distribution process," Azar "said that doses would be shipped

stage testing is complete," while the European Medicines Agency "has signaled it also is open to faster 'conditional' clearance." USA Today (11/30, Weintraub, 10.31M) reports Moderna's latest findings "showed that of 196 people in the clinical trial who caught COVID-19, 185 of them had received the placeb

based on states' total populations, forcing hard choices in states with a greater proportion of residents at high risk." The New York Times (11/30, Grady, Zraick, 18.61M) reports that on Monday, when "asked about the role of states in the distribution process," Azar "said that doses would be shipped o

fight the virus," and "while early studies show promise, mRNA technology has never been used to make a successful vaccine before." USA Today (7/27, Weintraub, 10.31M), the Washington Times (7/27, Neergaard, 492K), CQ Roll Call (7/27, Siddons, 154K) and New York Times (7/27, Grady, 18.61M), among other ne

." USA Today (7/27, Weintraub, 10.31M), the Washington Times (7/27, Neergaard, 492K), CQ Roll Call (7/27, Siddons, 154K) and New York Times (7/27, Grady, 18.61M), among other news outlets, also report the story. EFTA00150404 CNBC (7/27, Lovelace, Feuer, 3.62M) reports on its website, meanwhile, th

fight the virus," and "while early studies show promise, mRNA technology has never been used to make a successful vaccine before." USA Today (7/27, Weintraub, 10.31M), the Washington Times (7/27, Neergaard, 492K), CQ Roll Call (7/27, Siddons, 154K) and New York Times (7/27, Grady, 18.61M), among other ne

." USA Today (7/27, Weintraub, 10.31M), the Washington Times (7/27, Neergaard, 492K), CQ Roll Call (7/27, Siddons, 154K) and New York Times (7/27, Grady, 18.61M), among other news outlets, also report the story. CNBC (7/27, Lovelace, Feuer, 3.62M) reports on its website, meanwhile, that Moderna sha

stage testing is complete," while the European Medicines Agency "has signaled it also is open to faster `conditional' clearance." USA Today (11/30, Weintraub, 10.31M) reports Moderna's latest findings "showed that of 196 people in the clinical trial who caught COVID-19, 185 of them had received the placeb

based on states' total populations, forcing hard choices in states with a greater proportion of residents at high risk." The New York Times (11/30, Grady, Zraick, 18.61M) reports that on Monday, when "asked about the role of states in the distribution process," Azar "said that doses would be shipped o